<?xml version="1.0" encoding="UTF-8"?>
<p>The cessation of the capsid disintegration by viral or host enzymes/proteins is a drug target explored against the influenza virus, rhinoviruses, hepatitis A, poliovirus and enteroviruses (Yamauchi &amp; Greber, 
 <xref rid="tbed13734-bib-0095" ref-type="ref">2016</xref>). In accordance with this approach, rimantadine inhibits the capsid disintegration by blocking the ion channel in the influenza virus (Balgi et al., 
 <xref rid="tbed13734-bib-0009" ref-type="ref">2013</xref>). The herbal medicine of Japan called Maoto has also shown inhibitory activity on influenza virus A (PR8) presumed by inhibition of genome release (Masui et al., 
 <xref rid="tbed13734-bib-0051" ref-type="ref">2017</xref>).
</p>
